Atrial Cardiomyocytes, Cardiovascular Risk Assessment, Microphysiological System, Contractility, GPCR, HiPSC-CM, In vitro drug screening, Preclinical Drug Testing, safety pharmacology
Glycaemic Variability, Myocardial Infarction, Ischaemia-Reperfusion Injury, Human Induced Pluripotent Stem Cell, Cardiomyocytes, Maturation, Contractility, metabolism, Cardiac Cell Death, Mortality, UK Biobank Cohort